SIR Today
Mar 17, 2026
From multiple “first in human” applications to being the founding director of the NIH Center for Interventional Oncology, Dr. Wood has defined innovation in the field of interventional radiology.
Dr. AJ Gunn will be recognized as the first Early Career RISE Award recipient at SIR 2026. Listen to hear about his influences, clinical interests and key activities at SIR 2026.
Remembering a leader in international IR.
Behind the inspirations of a champion for women's health.
What drives the passion of an IR entrepreneur.
Prostate size should not be a key barrier to effective prostatic artery embolization—especially in oncologic patients—according to a new study.
Amid ongoing questions regarding prior authorization and value, researchers have shown that percutaneous vertebral augmentation for seniors with osteoporotic fractures are safe and effective at reducing opioid exposure.
A new first-in-human proof-of-concept study has shown that RF denervation of the somatosensory nerve can improve pain and quality of life while reducing opioid use.
Thyroid radiofrequency ablation versus thyroidectomy (RFA) offers a safe, thyroid-preserving alternative to surgery for select patients, according to a new study.
A novel approach for improving hyperglycemia in type 2 diabetics
New data emphasizes the nuance and complexity in patients with malignant biliary obstruction. Only half of patients who undergo PTBD placement for malignant biliary obstruction actually receive oncologic treatment.
Twenty years ago, Tara Graham, MD, attended her first Women in IR luncheon. She was a young medical student attending SIR 2006 in Toronto and just beginning to connect with the global community of interventional radiologists. At SIR 2026 in Toronto, Dr. Graham attended the Women in IR InspIRed Lecture and Luncheon
An interview with Saher S. Sabri, MD, FSIR
An interview with 2026 Frederick S. Keller, MD, Philanthropy Award winner Barry T. Katzen, MD, FSIR
Effective clot removal with Argon’s CLEANER Vac™